Daratumumab + lenalidomide MRD negative status in Griffin Study Multiple Myeloma 9 Mins Read0 The GRIFFIN Study is a post-hoc analysis of sustained MRD negative status in the griffin study which treated patients with…
Multiple Myeloma Dexamethasone, Daratumumab, Carfilzomib Phase 3 Data Multiple Myeloma 8 Mins Read0 The study that I will be discussing today is the frailty subgroup analysis of the CANDOR study, which is a…
